HIRSCHMAN ORIN 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 08:36 am Purchase | 2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE | HIRSCHMAN ORIN | 539,300 9.900% | 190,000 (+54.39%) | Filing |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE | HIRSCHMAN ORIN | 349,300 11.000% | 4,300 (+1.25%) | Filing |
| 2023-03-03 06:03 am Purchase | 2023-02-23 | 13G | Aprea Therapeutics, Inc. APRE | HIRSCHMAN ORIN | 345,000 11.000% | 345,000 (New Position) | Filing |